Lemborexant in Delayed Sleep Phase Syndrome — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Lemborexant in Delayed Sleep Phase Syndrome — Stella

Home/Delayed Sleep Phase Syndrome/

View on ClinicalTrials.gov

Recruiting

Back to Delayed Sleep Phase Syndrome trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

University of California San Francisco, San Francisco, California

Key details

Phase

Post-approval study

Sponsor

University of California, San Francisco

Collaborators

Eisai Co., Ltd., Stanford University

Enrollment target

~15 participants

Started

March 2023

Primary completion

May 2027

Age range

18 Years and older

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.